BRENDA BIRD: Open Payments
NPI 1942933148 · MADISON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 16 payments from 11 companies in 2025. Trend: 2023 $76 · 2024 $473 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $125 |
| ABBVIE INC. | 3 | $70 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Alkermes, Inc. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 1 | $40 |
| Tris Pharma Inc | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $21 |
Products named: Auvelity, VRAYLAR, COBENFY, Dyanavel XR, HETLIOZ, REXULTI, FANAPT, ARISTADA.
Industry payments across WI — which companies pay providers there.
